Preprint Brief Report Version 1 Preserved in Portico This version is not peer-reviewed

Caspofungin-Induced Cardiotoxicity in Patients Treating for Candidemia

Version 1 : Received: 23 July 2022 / Approved: 26 July 2022 / Online: 26 July 2022 (03:43:51 CEST)

How to cite: Sattarzadeh Badkoubeh, R.; Farajpour, M.; Salehi, M.; Sherafati, A.; Zamani, Z.; Rezahosseini, O.; Mansouri, P.; Sardari, A. Caspofungin-Induced Cardiotoxicity in Patients Treating for Candidemia. Preprints 2022, 2022070381 (doi: 10.20944/preprints202207.0381.v1). Sattarzadeh Badkoubeh, R.; Farajpour, M.; Salehi, M.; Sherafati, A.; Zamani, Z.; Rezahosseini, O.; Mansouri, P.; Sardari, A. Caspofungin-Induced Cardiotoxicity in Patients Treating for Candidemia. Preprints 2022, 2022070381 (doi: 10.20944/preprints202207.0381.v1).

Abstract

Echinocandins selectively inhibit fungal cell wall synthesis and, therefore, have few side effects. However, there are reports of hemodynamic and cardiac complications. We conducted this study to investigate the effects of caspofungin both on the noninvasive echocardiographic indices of myocardial function and on myocardial injury based on serum high-sensitivity cardiac troponin I (hs-cTnI) levels. This study was conducted on patients treated for candidemia. The hs-cTnI level and echocardiographic parameters were measured before and 1 hour after the infusion of the induction dose of caspofungin. Data were compared between central and peripheral venous drug administration routes. Fifteen patients were enrolled in the study. There were no significant differences in the echocardiographic parameters between the baseline and post-treatment period. The mean hs-cTnI level exhibited a significant rise following drug administration (0.24 ± 0.2 vs 0.32 ± 0.3; P = 0.006). There was also a significant difference concerning the hs-cTnI level between central and peripheral venous drug administration routes (P = 0.034). Due to differences in the hs-cTnI level, it appears that the administration of caspofungin may be associated with myocardial injury. Our findings also showed a higher possibility of cardiotoxicity via the central venous administration route.

Keywords

Caspofungin; Candidemia; Cardiotoxicity; Troponin

Subject

MEDICINE & PHARMACOLOGY, Cardiology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.

We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.